EcoDrugPlus

Cyclin Dependent Kinase 1

Ensembl ID : ENSCVAG00000021312
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSCVAG00000001860
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSCVAG00000001761
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSCVAG00000018643
Gene Symbol: CDK5
3 Cross references
168 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSCVAG00000014594
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSCVAG00000013203
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSCVAG00000004661
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1-Like

Ensembl ID : ENSCVAG00000006701
Gene Symbol: LOC107096073
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSCVAG00000006341
Gene Symbol: LOC107083322
3 Cross references
199 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSCVAG00000008500
Gene Symbol: LOC107087635
3 Cross references
194 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSCVAG00000000987
Gene Symbol: CYP19A1
3 Cross references
246 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSCVAG00000005085
Gene Symbol: LOC107091694
3 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).